Colorectal Cancer Screening: Why Patients Delay Colonoscopy After a Positive Test
- More than half a million people in France tested positive for colorectal cancer risk between 2016 and 2020, yet a new public health analysis reveals that nearly half...
- The epidemiological study tracks individuals step-by-step from the moment they receive a positive screening result.
- Colorectal cancer accounted for 47,800 estimated new cases in 2023, making it the second leading cause of cancer death in the country.
More than half a million people in France tested positive for colorectal cancer risk between 2016 and 2020, yet a new public health analysis reveals that nearly half of those patients failed to complete a follow-up colonoscopy within the vital three-month window. Data published in the March 10, 2026, issue of the Bulletin épidémiologique hebdomadaire show that exactly 52.2 percent of patients underwent the necessary diagnostic procedure at three months, leaving a substantial gap in timely clinical intervention for a malignancy that killed an estimated 16,930 people in 2023.
The Slow Timeline From Positive Test to Clinical Procedure
The epidemiological study tracks individuals step-by-step from the moment they receive a positive screening result. One month after receiving that result, only 4.7 percent of patients had actually completed their colonoscopy. The completion rate climbs slowly over the subsequent months before reaching 87 percent at the 24-month mark, leaving a stubborn minority of patients who never finish the diagnostic pathway. That sluggish progression contrasts sharply with European recommendations that set a 31-day target for post-screening diagnostics, prompting study authors to propose a more realistic domestic target of three to six months.
Colorectal cancer accounted for 47,800 estimated new cases in 2023, making it the second leading cause of cancer death in the country. Detecting the disease early dramatically shifts patient outcomes, allowing doctors to cure the condition in nine out of ten cases. However, participation in the initial screening test itself remains low, stalling at 30.7 percent for the 2024–2025 period and falling well short of the acceptable European threshold of 45 percent. On the single year of 2025, participation reached 33.1 percent, breaking down to 34.3 percent among women and 31.8 percent among men.
Geographic Disparities and Missing Primary Care Links
Geography plays an enormous role in whether a patient completes the diagnostic sequence. At the three-month mark, the proportion of completed colonoscopies ranges from a low of 26 percent in the Territoire de Belfort to 71 percent in the Morbihan, meaning a patient’s chances of receiving timely care vary by nearly a factor of three depending on their department. Researchers isolated one factor that outweighs all others in explaining these delays: when a positive test result is not transmitted to the primary care physician, the probability of a patient completing the colonoscopy is divided in half.
Certain demographic profiles also lag behind the national average. Men complete follow-up colonoscopies less frequently than women, and individuals taking the test for the first time drop out of the diagnostic chain more often than repeat participants. Adults aged 70 to 75 represent both the oldest bracket in the screening program and the least monitored group, while residents in economically disadvantaged zones show lower colonoscopy rates after a positive result. Since January 1, 2024, the Assurance maladie has taken over sending screening invitations, while regional cancer screening coordination centers track patients and results. Even with those administrative shifts, the primary care physician remains the essential link required to transform a positive test result into an actual appointment.
Financial Penalties and Remaining Questions for Patients
Without a primary care physician’s formal orientation, consultations with a gastroenterologist are reimbursed by social security at only 30 percent instead of the standard 70 percent. Furthermore, after a test positive, the colonoscopy sort du 100 % : 32 € restent sans mutuelle.
Public health authorities continue to promote four practical reflexes to prevent patients from remaining stuck between screening and diagnosis: formally declaring a primary care physician if one is not registered, explicitly noting the physician’s name during testing to ensure result transmission, scheduling a consultation immediately upon receiving results within two working days, and contacting regional coordination centers if no appointment materializes. Yet questions remain as to why regional disparities persist so sharply across departments, and whether upcoming administrative reforms can successfully close the multi-month gap before screening participation rates improve nationwide.
Related reading
- Ireland parents fear care crisis for disabled adult children
- Mutated H1N1 Strain Drives Early US Flu Season and West Coast Surge
- Health Ministry approves immune cell therapy research for colorectal cancer (archyde.com)
- Mass General Brigham Researchers Develop AI Tool to Assess Cancer Patients’ Mortality Risk from Facial Photos (newsy-today.com)
